AI assistant
Sending…
ORACLE CORP — Director's Dealing 2014
Dec 19, 2014
29742_dirs_2014-12-19_c842db78-e7d1-41cf-b9bb-c38ac6cbd885.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORACLE CORP (ORCL)
CIK: 0001341439
Period of Report: 2014-12-18
Reporting Person: HENLEY JEFFREY (Director, Chairman of the Board)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-18 | Common Stock | M | 400000 | $14.57 | Acquired | 400000 | Direct |
| 2014-12-18 | Common Stock | S | 400000 | $43.8252 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-12-18 | Stock Option | $14.57 | M | 400000 | Disposed | 2016-07-06 | Common Stock (400000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1934516 | Indirect |
Footnotes
F1: Sale of shares pursuant to Rule 10b5-1 Plan adopted on July 30, 2014.
F2: This transaction was executed in multiple trades at prices ranging from $43.67 to $43.98. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: Options vest 25% annually on anniversary of grant date.
More from ORACLE CORP
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 11
Regulatory Filings
2026
Feb 5
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 2